Shown to improve attention function, EndeavorRx is backed by data from five...
Shown to improve attention function, EndeavorRx is backed by data from five clinical studies, including a prospective, randomized controlled trial.
Source: Photo: Business Wire

Gamifiction: FDA clears first game-based digital therapeutic

Akili announced that the U.S. Food and Drug Administration (FDA) has granted clearance for EndeavorRxTM (AKL-T01) as a prescription treatment for children with attention deficit hyperactivity disorder (ADHD).

Delivered through a captivating video game experience, EndeavorRx is indicated to improve attention function as measured by computer-based testing in children ages 8-12 years old with primarily inattentive or combined-type ADHD, who have a demonstrated attention issue. See full indication below. Persistent attention issues have a significant impact on the daily lives of millions of people. Attention impairments are a key component of ADHD for many children yet are often overshadowed by more overt symptoms of ADHD.

EndeavorRx was reviewed through FDA’s de novo pathway and its clearance creates a new class of digital therapeutics. The game is designed to directly target and activate neural systems through the presentation of sensory stimuli and motor challenges to improve cognitive functioning. “We’re proud to make history today with FDA’s decision," said Eddie Martucci, Ph.D., chief executive officer of Akili. “With EndeavorRx, we’re using technology to help treat a condition in an entirely new way as we directly target neurological function through medicine that feels like entertainment. Families are looking for new ways to help their children with ADHD. With today’s decision by FDA, we’re excited to offer families a first-of-its-kind non-drug treatment option and take an important first step toward our goal to help all people living with cognitive issues.”

EndeavorRx was granted clearance based on data from five clinical studies in more than 600 children diagnosed with ADHD, including a prospective, randomized, controlled study published in The Lancet Digital Health journal, which showed EndeavorRx improved objective measures of attention in children with ADHD. After four weeks of EndeavorRx treatment, one-third of children no longer had a measurable attention deficit on at least one measure of objective attention. Further, about half of parents saw a clinically meaningful change in their child’s day-to-day impairments after one month of treatment with EndeavorRx; this increased to 68% after a second month of treatment. Improvements in ADHD impairments following a month of treatment with EndeavorRx were maintained for up to a month.

"For children living with ADHD, improving their ability to focus and resist distraction is critical to their daily functioning and performance in school,” said Elysa Marco, M.D., cognitive and behavioral child neurologist and Clinical Executive for Neurodevelopmental Medicine at Cortica Healthcare. “Unlike traditional ADHD medications, EndeavorRx is designed to specifically target inattention. Based on the benefits my research participants and patients have experienced, I am thrilled that EndeavorRx is moving from the lab to the clinic to play an essential role as part of a comprehensive treatment plan for children with ADHD.”

The EndeavorRx treatment will be available with a prescription to families soon. Akili believes that cognitive impairments require the same constant attention and care as with any other chronic condition. The game will be released as the centerpiece of the Endeavor Care Program, which includes the EndeavorRx treatment and Akili Care,TM a mobile tracking app and personal support services for caregivers. Easily accessible from home, the game is downloaded from the App Store by families on their mobile devices and does not require any additional equipment.

“The clearance of EndeavorRx marks the culmination of nearly a decade of research and development and was fueled by the commitment of our team and collaborators to challenge the status quo of medicine. This would not have been possible without the dedication of our clinical research partners and hundreds of families who gave their time and energy to participate in our clinical trials,” said Scott Kellogg, senior vice president of medical devices at Akili.

Subscribe to our newsletter

Related articles

Video-game therapy may help treat ADHD

Video-game therapy may help treat ADHD

A trial suggests that a digital intervention for paediatric ADHD might help to improve inattention with minimal adverse effects.

Video game to treat children with ADHD

Video game to treat children with ADHD

Researchers have developed advanced brain-computer interface technology that harnesses machine learning to personalise brain-training for children with ADHD.

Children with autism: Video game-based “digital medicine” could help

Children with autism: Video game-based “digital medicine” could help

Researchers evaluated a digital medicine tool designed as an investigational treatment for children with autism spectrum disorder (ASD) and co-occurring ADHD.

A video game may improve empathy in middle schoolers

A video game may improve empathy in middle schoolers

Researchers have developed a video game to study whether video games can boost kids' empathy, and to understand how learning such skills can change neural connections in the brain.

Robot toys provide clues about infant development

Robot toys provide clues about infant development

New research shows that using robots could help detect early signs of autism or ADHD in infants.

Mental health game changer

Mental health game changer

Using a simple computer game and AI techniques, researchers were able to identify behavioural patterns in subjects with depression and bipolar disorder.

Virtual reality: Avatars against obesity

Virtual reality: Avatars against obesity

A collaborative project develops virtual reality methods to positively affect the body perception of obese patients.

Mentally ill avatars

Mentally ill avatars

To teach medical students, scientists have created avatars that feature typical symptoms of different mental disorders as well as psychiatric and psychotherapeutic treatment situations.

Using game tech to treat cognitively impaired children in Africa

Using game tech to treat cognitively impaired children in Africa

Using a game, researchers are rehabilitating children who suffer from cognitive impairment after surviving life-threatening diseases such as malaria and HIV.

Popular articles